Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.30 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9400013 | 0.90 | HSPD1 (0.38) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL8746528 | 0.87 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL6663512 | 0.85 | HSPD1 (0.37) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL820028 | 0.82 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL375645 | 0.82 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL285119 | 0.82 | HSPD1 (0.43) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL124007 | 0.81 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL16527346 | 0.80 | — | — | |
| SCHEMBL690431 | 0.79 | HSPD1 (0.37) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL16341864 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030072798-A1 | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2003-04-17 | — | — | US | claimed |
| US-20020102301-A1 | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2002-08-01 | — | — | US | claimed |
| US-20020102301-A1 | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2002-08-01 | — | — | US | disclosed |
| US-20020103139-A1 | Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control | ALPHARX INC. (CA) | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103139-A1 | Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control | CETP, CYP46A1, NPC1L1 | HSPD1 1599/4885BLM 1821/4885HSPE1 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.